The week in review

Semaglutide made the news again, as did the question of whether patients need to sign for PBS items We heard from Professor Gary Wittert from the University of Adelaide on the subject of regulating the compounding of Ozempic; meanwhile we heard from the ABC's Four Corners program that a pharmacist (whose registration includes conditions barring